Milk Allergy Clinical Trial
Official title:
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
The purpose of this study is to determine if a new extensively hydrolyzed formula can be consumed by children with Cow's Milk Allergy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01950533 -
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
|
||
| Completed |
NCT02579876 -
Milk Patch for Eosinophilic Esophagitis
|
Phase 2 | |
| Completed |
NCT04318483 -
Characteristic and Evolution of an Atypical IgE-mediated Cow Milk Allergy Form With Hands and Feet Angio-oedema
|
||
| Completed |
NCT00968110 -
Xolair Treatment for Milk Allergic Children
|
Early Phase 1 | |
| Recruiting |
NCT03309488 -
Basophil Activation Test to Diagnose Food Allergy
|
||
| Completed |
NCT00328731 -
Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05309772 -
The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy
|
N/A | |
| Terminated |
NCT02719405 -
Impact of Infant Formula on Resolution of Cow's Milk Allergy
|
Phase 2 | |
| Completed |
NCT01361347 -
Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children
|
Phase 4 | |
| Completed |
NCT01157117 -
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
|
Phase 2 | |
| Active, not recruiting |
NCT00732654 -
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03819556 -
Swedish Study of Immunotherapy for Milk Allergy in Children
|
N/A |